The recent advancements and developments reached in the field of Respiratory Pharmacology, especially over the past year, have been exceptional and are the result of the great achievements made by researchers and scientists thus far.
In order to explore this fast-growing field, Frontiers is launching a new series of Research Topics focusing on the evolution of methods, processes, techniques and ways of thinking in Respiratory Pharmacology that led to new discoveries and research approaches.
In this article collection, we seek contributions exploring the changing context and the rising new perspectives within Respiratory Pharmacology. The emphasis of this series is on the dynamics of change and evolution of the latest progresses made, as well as on the evolving methods and responses in research across the field of Respiratory Pharmacology. This article collection aims to inform, inspire and provide direction and guidance to researchers in the field.
This topic welcomes submissions of the following article types: Case Report, Clinical Trial, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Technology and Code. The topic welcomes manuscripts covering, but not limited to the following themes:
- New perspectives in drug development approaches and methods to treat respiratory diseases (including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer)
- Recent advances in efforts towards more personalized and more rational pharmacological therapy of respiratory diseases
- Novel techniques implemented in respiratory disease drug discovery
- Recent methods to identify causal biological pathways and clinically relevant biomarkers of respiratory diseases, to facilitate accurate diagnosis and treatment approaches
- Emerging therapeutic candidates on the horizon for the treatment of respiratory diseases
- Improvements made on the existing classes of drug traditionally used to treat respiratory diseases
The recent advancements and developments reached in the field of Respiratory Pharmacology, especially over the past year, have been exceptional and are the result of the great achievements made by researchers and scientists thus far.
In order to explore this fast-growing field, Frontiers is launching a new series of Research Topics focusing on the evolution of methods, processes, techniques and ways of thinking in Respiratory Pharmacology that led to new discoveries and research approaches.
In this article collection, we seek contributions exploring the changing context and the rising new perspectives within Respiratory Pharmacology. The emphasis of this series is on the dynamics of change and evolution of the latest progresses made, as well as on the evolving methods and responses in research across the field of Respiratory Pharmacology. This article collection aims to inform, inspire and provide direction and guidance to researchers in the field.
This topic welcomes submissions of the following article types: Case Report, Clinical Trial, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Technology and Code. The topic welcomes manuscripts covering, but not limited to the following themes:
- New perspectives in drug development approaches and methods to treat respiratory diseases (including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer)
- Recent advances in efforts towards more personalized and more rational pharmacological therapy of respiratory diseases
- Novel techniques implemented in respiratory disease drug discovery
- Recent methods to identify causal biological pathways and clinically relevant biomarkers of respiratory diseases, to facilitate accurate diagnosis and treatment approaches
- Emerging therapeutic candidates on the horizon for the treatment of respiratory diseases
- Improvements made on the existing classes of drug traditionally used to treat respiratory diseases
